Literature DB >> 21093921

A standardized grading system for scleritis.

H Nida Sen1, Amit A Sangave, Debra A Goldstein, Eric B Suhler, Denise Cunningham, Susan Vitale, Robert B Nussenblatt.   

Abstract

OBJECTIVE: This study evaluated the performance of a standardized grading system for scleritis using standard digital photographs.
DESIGN: Cross-sectional interobserver agreement study. PARTICIPANTS: Photo archives from the National Eye Institute.
METHODS: Three uveitis specialists from 3 different centers graded 79 randomly arranged images of the sclera with various degrees of inflammation. Grading was done using standard screen resolution (1024×768 pixels) on a 0 to 4+ scale in 2 sessions: (1) without using reference photographs and (2) with reference to a set of standard photographs (proposed grading system). The graders were masked to the order of images, and the order of images was randomized. Interobserver agreement in grading the severity of inflammation with and without the use of grading system was evaluated. MAIN OUTCOME MEASURES: Interobserver agreement.
RESULTS: The proposed grading system for assessing activity in scleritis demonstrated a good interobserver agreement. Interobserver agreement (pooled κ) was poor (0.289) without photographic guidance and improved substantially when the "grading system" with standardized photographs was used (κ = 0.603).
CONCLUSIONS: This system of standardized images for scleritis grading provides significantly more consistent grading of scleral inflammation in this study and has clear applications in clinical settings and clinical research.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093921      PMCID: PMC3070789          DOI: 10.1016/j.ophtha.2010.08.027

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

2.  Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation.

Authors:  P G Watson
Journal:  Trans Ophthalmol Soc U K       Date:  1982-07

3.  Standardization of vitreal inflammatory activity in intermediate and posterior uveitis.

Authors:  R B Nussenblatt; A G Palestine; C C Chan; F Roberge
Journal:  Ophthalmology       Date:  1985-04       Impact factor: 12.079

4.  Prediction of response to treatment in patients with scleritis using a standardised scoring system.

Authors:  P McCluskey; D Wakefield
Journal:  Aust N Z J Ophthalmol       Date:  1991-08

5.  Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.

Authors:  Simon R J Taylor; Alan D Salama; Lavnish Joshi; Charles D Pusey; Susan L Lightman
Journal:  Arthritis Rheum       Date:  2009-05

6.  Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis.

Authors:  John H Kempen; Sudha K Ganesh; Virender S Sangwan; Sivakumar R Rathinam
Journal:  Am J Ophthalmol       Date:  2008-08-08       Impact factor: 5.258

7.  Infliximab for the treatment of active scleritis.

Authors:  H Nida Sen; Amit Sangave; Keri Hammel; Grace Levy-Clarke; Robert B Nussenblatt
Journal:  Can J Ophthalmol       Date:  2009-06       Impact factor: 1.882

Review 8.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

  8 in total
  19 in total

Review 1.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

2.  Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.

Authors:  Nirali Bhatt; Monica Dalal; William Tucker; Dominic Obiyor; Robert Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2014-12-17       Impact factor: 5.258

3.  Ocular inflammation associated with relapsing polychondritis in Japanese patients: a review of 11 patients.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Hisae Nakahara; Keiko Komae
Journal:  Int Ophthalmol       Date:  2019-05-10       Impact factor: 2.031

Review 4.  [Diagnosis and treatment of episcleritis and scleritis].

Authors:  C Tappeiner; K Walscheid; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

5.  Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.

Authors:  Cheng-Rong Yu; Rashid R Mahdi; Hyun-Mee Oh; Ahjoku Amadi-Obi; Grace Levy-Clarke; Jenna Burton; Amarachi Eseonu; Yongjun Lee; Chi-Chao Chan; Charles E Egwuagu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

6.  Clinical patterns and risk factors in scleritis: a multicentric study in Colombia.

Authors:  Alejandra de-la-Torre; Mariana Cabrera-Pérez; Claudia Durán; Sandra García; Miguel Cuevas; Néstor Carreño; Carlos M Rangel; Diana Isabel Pachón-Suárez; María Alejandra Martínez-Ceballos; María Elisa Mejía; Alejandra Gómez-Rocha; Camilo Andrés Gómez-Durán; Yanny Pérez; Juliana Reyes-Guanes; Carlos Cifuentes-González; William Rojas-Carabali
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-07       Impact factor: 3.117

7.  Methotrexate for chronic non-necrotizing anterior scleritis in Chinese patients.

Authors:  Jun-Yan Xiao; An-Yi Liang; Fei Gao; Chan Zhao; Mei-Fen Zhang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

8.  Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.

Authors:  Jared E Knickelbein; William R Tucker; Nirali Bhatt; Karen Armbrust; David Valent; Dominic Obiyor; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2016-09-20       Impact factor: 5.258

9.  Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis.

Authors:  Ashleigh L Levison; Careen Y Lowder; Kimberly M Baynes; Peter K Kaiser; Sunil K Srivastava
Journal:  Int Ophthalmol       Date:  2015-11-23       Impact factor: 2.031

10.  Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis.

Authors:  Haruka Aoki; Miki Hiraoka; Masato Hashimoto; Hiroshi Ohguro
Journal:  Case Rep Ophthalmol       Date:  2015-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.